ClariVest Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q3 | – | Sell |
-63,566
| Closed | -$1.13M | – | 697 |
|
2022
Q2 | $1.13M | Hold |
63,566
| – | – | 0.05% | 258 |
|
2022
Q1 | $1.29M | Buy |
63,566
+28,766
| +83% | +$586K | 0.05% | 260 |
|
2021
Q4 | $650K | Sell |
34,800
-600
| -2% | -$11.2K | 0.02% | 396 |
|
2021
Q3 | $699K | Sell |
35,400
-300
| -0.8% | -$5.92K | 0.02% | 379 |
|
2021
Q2 | $844K | Hold |
35,700
| – | – | 0.03% | 326 |
|
2021
Q1 | $846K | Buy |
35,700
+1,900
| +6% | +$45K | 0.03% | 307 |
|
2020
Q4 | $677K | Sell |
33,800
-698
| -2% | -$14K | 0.02% | 329 |
|
2020
Q3 | $718K | Sell |
34,498
-2,100
| -6% | -$43.7K | 0.02% | 326 |
|
2020
Q2 | $641K | Sell |
36,598
-10,144
| -22% | -$178K | 0.02% | 367 |
|
2020
Q1 | $763K | Buy |
46,742
+7,142
| +18% | +$117K | 0.02% | 339 |
|
2019
Q4 | $815K | Sell |
39,600
-400
| -1% | -$8.23K | 0.02% | 377 |
|
2019
Q3 | $459K | Sell |
40,000
-200
| -0.5% | -$2.3K | 0.01% | 420 |
|
2019
Q2 | $529K | Buy |
+40,200
| New | +$529K | 0.01% | 362 |
|